June 29, 2018
Mitsubishi Tanabe Pharma said on June 28 that it has updated the framework of its existing copromotion deal with Janssen Pharmaceutical for the anti-IL-12/23 p40 monoclonal antibody Stelara (ustekinumab). The two companies have been copromoting the therapy for Crohn’s disease...read more